FDI in Pharma May Get Relaxation
After much hullabaloo the Foreign Direct Investment (FDI) policy for Pharma may get reconsideration. As per a senior finance minister […]
After much hullabaloo the Foreign Direct Investment (FDI) policy for Pharma may get reconsideration. As per a senior finance minister […]
Som Panicker, Vice President, Sanrad Medical Systems, believes that the Indian healthcare sector is poised for a massive investment from […]
Rajeev Agarwal, Business Head, Healthcare Informatics, Philips, believes that supply of good quality healthcare specialists is a constraint to healthcare […]
Kewal Handa Managing Director, Pfizer Ltd Kewal Handa is recognised as an industry expert on issues concerning the pharmaceutical sector. […]
Indias healthcare sector is in a dynamic phase of growth but technology must work towards affordable healthcare By Dhirendra Pratap […]
[This article was published in the June 2011 issue of the eHEALTH Magazine (https://www.ehealthonline.org) ] Technological advancements and growing clinical applications have made MRI one of the most sought after imaging techniques
The research-based pharma companies are mounting pressure for stronger regulatory data protection laws.
[This article was published in the November 2010 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
Promoting indigenous medical technology innovations is crucial for maintaining the current momentum of growth in the Indian medical technology industry
[This article was published in the October 2010 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
Satish Kini�s continuing quest to find his purpose in life
At a time when global multinational drug makers are slashing their workforces to reduce costs, their Indian counterparts are on a hiring spree.
[This article was published in the May 2009 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
While healthcare becomes ever more complex, technology is providing answers for some of the most challenging aspects of medicine. eHealth brings you a low down on medical technologies that are changing the way we provide clinical care.
In a move that would prevent MNCs such as GlaxoSmithKline (GSK), Eli Lilly, Roche and Pfizer from selling their drugs at a huge premium in India, the government may soon finalise norms for monitoring prices of costly imported patented medicines for diseases such as diabetes, arthritis, obesity, cancer and heart diseases.
Sysmex, Transasia introduce products for Clinical Research sector Sysmex, the world leader in Haematology, in partnership with Transasia Bio-Medicals introduced […]